Cellectar Biosciences (CLRB) Reports FY Loss of $3.11

March 27, 2024 7:25 AM

Cellectar Biosciences (NASDAQ: CLRB) reported FY EPS of ($3.11).

For earnings history and earnings-related data on Cellectar Biosciences (CLRB) click here.